{"id":"https://openalex.org/W1965367208","doi":"https://doi.org/10.1055/s-0031-1297994","title":"Hypogonadism Secondary to Hyperprolactinaemia: Successful Treatment but Adverse Consequences","display_name":"Hypogonadism Secondary to Hyperprolactinaemia: Successful Treatment but Adverse Consequences","publication_year":2012,"publication_date":"2012-03-22","ids":{"openalex":"https://openalex.org/W1965367208","doi":"https://doi.org/10.1055/s-0031-1297994","mag":"1965367208","pmid":"https://pubmed.ncbi.nlm.nih.gov/22441722"},"language":"en","primary_location":{"id":"doi:10.1055/s-0031-1297994","doi":"https://doi.org/10.1055/s-0031-1297994","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0031-1297994","pdf_url":null,"source":{"id":"https://openalex.org/S67343978","display_name":"Experimental and Clinical Endocrinology & Diabetes","issn_l":"0947-7349","issn":["0947-7349","1439-3646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Endocrinology & Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019698519","display_name":"Ram Prakash Narayanan","orcid":"https://orcid.org/0000-0003-2840-6507","observed_orcids":["https://orcid.org/0000-0003-2840-6507"]},"institutions":[{"id":"https://openalex.org/I2800535034","display_name":"Leighton Hospital","ror":"https://ror.org/04mx3cr06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I196539022","https://openalex.org/I2800535034"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Narayanan","raw_affiliation_strings":["Leighton Hospital, Crewe, UK, Cheshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leighton Hospital, Crewe, UK, Cheshire","institution_ids":["https://openalex.org/I2800535034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071545350","display_name":"Sumudu Bujawansa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800535034","display_name":"Leighton Hospital","ror":"https://ror.org/04mx3cr06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I196539022","https://openalex.org/I2800535034"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Bujawansa","raw_affiliation_strings":["Leighton Hospital, Crewe, UK, Cheshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leighton Hospital, Crewe, UK, Cheshire","institution_ids":["https://openalex.org/I2800535034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111112784","display_name":"Z. Qureshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800535034","display_name":"Leighton Hospital","ror":"https://ror.org/04mx3cr06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I196539022","https://openalex.org/I2800535034"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Z. Qureshi","raw_affiliation_strings":["Leighton Hospital, Crewe, UK, Cheshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leighton Hospital, Crewe, UK, Cheshire","institution_ids":["https://openalex.org/I2800535034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051090045","display_name":"Michael P. Rimmer","orcid":"https://orcid.org/0000-0002-3295-8753","observed_orcids":["https://orcid.org/0000-0002-3295-8753"]},"institutions":[{"id":"https://openalex.org/I2800535034","display_name":"Leighton Hospital","ror":"https://ror.org/04mx3cr06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I196539022","https://openalex.org/I2800535034"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Rimmer","raw_affiliation_strings":["Leighton Hospital, Crewe, UK, Cheshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leighton Hospital, Crewe, UK, Cheshire","institution_ids":["https://openalex.org/I2800535034"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083538986","display_name":"Adrian Hugh Heald","orcid":"https://orcid.org/0000-0002-9537-4050","observed_orcids":["https://orcid.org/0000-0002-9537-4050","https://orcid.org/0009-0009-1515-9747"]},"institutions":[{"id":"https://openalex.org/I2800535034","display_name":"Leighton Hospital","ror":"https://ror.org/04mx3cr06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I196539022","https://openalex.org/I2800535034"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Heald","raw_affiliation_strings":["Department of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, UK","Leighton Hospital, Crewe, UK, Cheshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Leighton Hospital, Crewe, UK, Cheshire","institution_ids":["https://openalex.org/I2800535034"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2059,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.57110471,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"120","issue":"05","first_page":"311","last_page":"313"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.052000001072883606,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypogonadism","display_name":"hypogonadism","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hyperprolactinemia","display_name":"hyperprolactinemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/testosterone-replacement-therapy","display_name":"testosterone replacement therapy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/irritability","display_name":"irritability","score":0.6489999890327454},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.9480000138282776},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2780820931","wikidata":"https://www.wikidata.org/wiki/Q29299","display_name":"Irritability","level":3,"score":0.8954157829284668},{"id":"https://openalex.org/C2781401123","wikidata":"https://www.wikidata.org/wiki/Q1433936","display_name":"Hyperprolactinaemia","level":4,"score":0.794072151184082},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.67453932762146},{"id":"https://openalex.org/C2779448149","wikidata":"https://www.wikidata.org/wiki/Q191797","display_name":"Aggression","level":2,"score":0.6496871709823608},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6401669383049011},{"id":"https://openalex.org/C2779279991","wikidata":"https://www.wikidata.org/wiki/Q6058681","display_name":"Testosterone (patch)","level":2,"score":0.6202892065048218},{"id":"https://openalex.org/C3019419337","wikidata":"https://www.wikidata.org/wiki/Q4759440","display_name":"Testosterone replacement","level":4,"score":0.5046557188034058},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.4314335286617279},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33975470066070557},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3393806219100952},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3267107605934143},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2896045446395874},{"id":"https://openalex.org/C2778562196","wikidata":"https://www.wikidata.org/wiki/Q177708","display_name":"Menopause","level":2,"score":0.17379674315452576},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.11105379462242126},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.10485562682151794}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001521","descriptor_name":"Behavior Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D007006","descriptor_name":"Hypogonadism","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007006","descriptor_name":"Hypogonadism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010911","descriptor_name":"Pituitary Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010911","descriptor_name":"Pituitary Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010911","descriptor_name":"Pituitary Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1055/s-0031-1297994","doi":"https://doi.org/10.1055/s-0031-1297994","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0031-1297994","pdf_url":null,"source":{"id":"https://openalex.org/S67343978","display_name":"Experimental and Clinical Endocrinology & Diabetes","issn_l":"0947-7349","issn":["0947-7349","1439-3646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Endocrinology & Diabetes","raw_type":"journal-article"},{"id":"pmid:22441722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22441722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","raw_type":"Case Reports"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/7a75cbf4-0852-42f2-857d-a2d28ba1daab","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/7a75cbf4-0852-42f2-857d-a2d28ba1daab","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Narayanan, R P, Bujawansa, S, Qureshi, Z, Rimmer, M & Heald, A 2012, 'Hypogonadism secondary to hyperprolactinaemia: Successful treatment but adverse consequences', Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 5, pp. 311-313. https://doi.org/10.1055/s-0031-1297994","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2804666263","https://openalex.org/W2059409386","https://openalex.org/W6939487765","https://openalex.org/W2144128539","https://openalex.org/W2984447496","https://openalex.org/W4401691127","https://openalex.org/W2023056411","https://openalex.org/W4411522753","https://openalex.org/W2062560824","https://openalex.org/W2978415541"],"abstract_inverted_index":{"It":[0],"is":[1,22],"accepted":[2],"that":[3],"care":[4],"must":[5],"be":[6],"taken":[7],"in":[8,12],"initiating":[9],"testosterone":[10,32],"replacement":[11],"hypogonadal":[13],"individuals":[14],"with":[15],"historically":[16],"low":[17,54],"androgen":[18],"levels.":[19],"However":[20],"less":[21],"reported":[23],"about":[24],"the":[25,39],"influence":[26],"of":[27,29,42,45],"restoration":[28],"normal":[30],"endogenous":[31],"production":[33],"on":[34],"behaviour.Here":[35],"we":[36],"report":[37],"how":[38],"adverse":[40],"sequelae":[41],"successful":[43],"treatment":[44],"hypogonadism":[46],"secondary":[47],"to":[48,56],"hyperprolactinaemia,":[49],"manifesting":[50],"as":[51],"irritability":[52],"and":[53,66],"threshold":[55],"aggression,":[57],"were":[58],"managed":[59],"through":[60],"a":[61],"joint":[62],"approach":[63],"between":[64],"psychiatrist":[65],"physician.":[67]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}